Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 6/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PSMB5 | P28074 | 9/20 | 0.37 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.37 |
| ▸ | CMA1 | P23946 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9764845 | 0.83 | MAOB (0.42) | MAOBHSD17B2ADORA2BKMT2APSMB5 | |
| SCHEMBL9764925 | 0.83 | ALOX5 (0.45) | MAOBHSD17B2ADORA2BKMT2APSMB5 | |
| SCHEMBL9764899 | 0.80 | MAOB (0.42) | MAOBHSD17B2ADORA2BKMT2APSMB5 | |
| SCHEMBL10593685 | 0.75 | MAOB (0.41) | MAOBHSD17B2ADORA2BKMT2A | |
| SCHEMBL9764875 | 0.74 | ALOX5 (0.48) | HSD17B2CMA1 | |
| SCHEMBL10561811 | 0.72 | ALOX5 (0.43) | MAOBHSD17B2ADORA2BKMT2APSMB5 | |
| SCHEMBL9764881 | 0.69 | MAOB (0.43) | MAOBKMT2APSMB5PSMB8CMA1 | |
| SCHEMBL9764924 | 0.68 | ALOX5 (0.43) | MAOBHSD17B2KMT2APSMB5 | |
| SCHEMBL4474107 | 0.67 | MAOB (0.50) | MAOBHSD17B2ADORA2BKMT2APSMB5 | |
| SCHEMBL10560471 | 0.67 | MAOB (0.37) | MAOBADORA2BPSMB5PSMB8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0422079-A4 | TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE | — | 1991-08-21 | — | — | EP | disclosed |
| EP-0422079-A1 | TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE | ABBOTT LABORATORIES (US) | 1991-04-17 | — | — | EP | disclosed |
| WO-1989012636-A1 | TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE | ABBOTT LABORATORIES (US) | 1989-12-28 | — | — | WO | disclosed |